Sareum Hldgs Plc Asset Resilience Ratio

Latest as of June 2019: 0.00%

Sareum Hldgs Plc asset resilience ratio. Sareum Hldgs Plc (SAR) has an Asset Resilience Ratio of 0.00% as of June 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Sareum Hldgs Plc (SAR) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

GBX1.00
≈ $0.00 USD Cash + Short-term Investments

Total Assets

GBX1.24 Million
≈ $151.01 USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Sareum Hldgs Plc (2014–2021)

Asset resilience ratio of Sareum Hldgs Plc from 2014 to 2021. This chart shows how Sareum Hldgs Plc's Asset Resilience Ratio has changed over time. Read Sareum Hldgs Plc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sareum Hldgs Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SAR asset base.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX1.00 0.0%
Total Liquid Assets GBX1.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Sareum Hldgs Plc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sareum Hldgs Plc Industry Peers by Asset Resilience Ratio

Compare Sareum Hldgs Plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
Biotechnology 21.11%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
Biotechnology 35.16%
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294
Biotechnology 23.15%
Wuhan Keqian Biology Co Ltd
SHG:688526
Biotechnology 19.42%
Achieve Life Sciences Inc
F:SP4P
Biotechnology 3.60%

Sareum Hldgs Plc Asset Resilience Ratio by Year (2014–2021)

Sareum Hldgs Plc asset resilience ratio by year from 2014 to 2021. The table below shows the annual Asset Resilience Ratio data for Sareum Hldgs Plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-06-30 87.24% GBX2.69 Million
≈ $326.83
GBX3.08 Million
≈ $374.65
-2.39pp
2020-06-30 89.63% GBX1.79 Million
≈ $218.34
GBX2.00 Million
≈ $243.60
+89.63pp
2019-06-30 0.00% GBX1.00
≈ $0.00
GBX1.24 Million
≈ $151.01
-75.37pp
2018-06-30 75.37% GBX1.37 Million
≈ $166.53
GBX1.82 Million
≈ $220.96
-16.45pp
2017-06-30 91.82% GBX2.30 Million
≈ $279.41
GBX2.50 Million
≈ $304.32
+80.63pp
2014-06-30 11.18% GBX200.00K
≈ $24.33
GBX1.79 Million
≈ $217.58
--
pp = percentage points

About Sareum Hldgs Plc

LSE:SAR UK Biotechnology
Market Cap
$257.11K
GBX2.11 Billion GBX
Market Cap Rank
#31297 Global
#997 in UK
Share Price
GBX15.25
Change (1 day)
+0.00%
52-Week Range
GBX12.00 - GBX37.00
All Time High
GBX457.50
About

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also develops SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical st… Read more